View in EDS HTML Full Text PDF Full Text

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.

Saved in:
Bibliographic Details
Title: Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
Authors: Gu, Chunyan1,2 (AUTHOR), Wang, Yajun2 (AUTHOR), Zhang, Lulin3 (AUTHOR), Qiao, Li2 (AUTHOR), Sun, Shanliang3 (AUTHOR), Shao, Miaomiao2 (AUTHOR), Tang, Xiaozhu2 (AUTHOR), Ding, Pinggang2 (AUTHOR), Tang, Chao2 (AUTHOR), Cao, Yuhao2 (AUTHOR), Zhou, Yanyan2 (AUTHOR), Guo, Mengjie2 (AUTHOR), Wei, Rongfang2 (AUTHOR), Li, Nianguang3 (AUTHOR) linianguang@njucm.edu.cn, Xiao, Yibei4 (AUTHOR) yibei.xiao@cpu.edu.cn, Duan, Jinao3,5 (AUTHOR) dja@njucm.edu.cn, Yang, Ye2 (AUTHOR) yangye876@sina.com
Source: Journal of Experimental & Clinical Cancer Research (17569966). 4/19/2023, Vol. 42 Issue 1, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-023-02672-7